IndraLab

Statements

CYLD leads to the deubiquitination of TAB1. 1 / 1

| 1

➶

reach

"CYLD does not inhibit TAK1 and TAB1 co-overexpression-induced TAK1 polyubiquitination."

21331078

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

CYLD leads to the deubiquitination of TAB1. 1 / 1

INDRA sources:

Databases

Reading